Search Results for "massachusetts"

Cresco Labs and Columbia Care Terminate $2B Merger

Multi-state cannabis operators Cresco Labs and Columbia Care on Sunday announced they would not be completing their merger, saying the companies could not complete “the divestitures necessary to secure all necessary regulatory approvals.” 

In March, Cresco had agreed to acquire Columbia Care in a $2 billion deal, which would have created the largest multi-state operator in the U.S. Neither company will pay any penalties or fees related to the decision, which the companies described as mutual.   

In a statement, Cresco CEO Charles Bachtell said that despite the termination of the deal, the company remains committed to its “Year of the Core strategy” which Bachtell described as “restructuring of low-margin operations, improving competitiveness and driving efficiencies in markets” where Cresco maintains “leading market share, and scaling operations to prepare for growth catalysts in emerging markets.”   

“In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders.” — Bachtell in a press release 

Nicholas Vita, CEO and co-founder of Columbia Care, called ending the deal “the best path forward” for the company’s employees, customers, and shareholders. 

“Over the last 16 months we have reviewed every aspect of our business, remained decisive and have made substantive changes that significantly improved our operations – positioning us with significant strategic and operational strength at this inflection point in the company’s history,” Vita said in a statement. “We are looking forward to realizing the benefits of these changes as well as focusing on the opportunities in our outstanding footprint in markets with embedded upside; diversified portfolio of brands; our award-winning national retail brand, The Cannabist; recently implemented operational and organizational efficiencies; proactive balance sheet management activities; and meaningful equity capital markets initiatives that will propel Columbia Care into one of the most profitable and resilient companies in the industry over the next several years.” 

The companies also terminated a deal to sell some divested operations in New York, Massachusetts, and Illinois to an entity owned by Sean “Diddy” Combs for up to $185 million. 

End


Study: 91% of Military Vet Cannabis Patients Say It Improved Their Quality of Life

A study published last month in the journal Clinical Therapeutics found that 91% of military veterans who use medical cannabis said it improved their quality of life. Most participants in the self-reported survey said they used cannabis daily. 

The survey, which included 510 U.S. military veterans, found 38% of respondents had chronic pain, 26% suffered from post-traumatic stress disorder, 9% reported having anxiety, and 5% suffered from depression. Many respondents said they consumed cannabis to reduce the use of over-the-counter medications (30%), including antidepressants (25%), anti-inflammatories (17%), and other prescription medications. Additionally, 21% of respondents reported using fewer opioids as a result of their medical cannabis use. 

“Medicinal cannabis use was reported to improve quality of life and reduce unwanted medication use by many of the study participants. The present findings indicate that medicinal cannabis can potentially play a harm-reduction role, helping veterans to use fewer pharmaceutical medications and other substances. Clinicians should be mindful of the potential associations between race, sex, and combat experience and the intentions for and frequency of medicinal cannabis use.” — “Self-reported Medicinal Cannabis Use as an Alternative to Prescription and Over-the-counter Medication Use Among US Military Veterans,” Clinical Therapeutics, June 2023  

The study’s authors said the findings “should inform clinicians who work with the veteran population, as cannabis may be an effective means of helping veterans, especially women and racially minoritized members of this population, to reduce unwanted medication use.” 

Among the participants, most identified as White (78%), followed by Latino or Hispanic (6%), Black (4%), and “other” (4%), while 9% of respondents preferred not to answer. Eighty-two percent of the respondents were men, 16% were women, and 2% preferred not to select a sex. 

The study included researchers from Boston, Massachusetts’ Cannabis Center of Excellence Inc.; the University of Utah; Rider University in New Jersey; Mansfield, Massachusetts-based Joint Venture & Co.; and the University of Massachusetts. 

End


Leafly Removes Articles Investigating Worker Death at Trulieve Facility

Online cannabis platform Leafly recently removed two in-depth articles investigating the death of cannabis worker Lorna McMurrey, 27, who passed away after collapsing during her shift at a Trulieve cannabis factory in Holyoke, Massachusetts. Mike Crawford, the host of The Young Jurks podcast in Massachusetts, which broke the news of McMurrey’s death, first posted about the articles’ removal last week on LinkedIn.

Leafly, which closed down its newsroom in March after reporting financial difficulties, offered no explanation for why the stories were pulled, according to a WeedWeek report investigating the missing articles.

Part 1 and Part 2 of Leafly’s removed investigative series can still be accessed via the Internet Wayback Machine. Written by Dave Howard, the articles focus on the cause of McMurrey’s death — the federal Occupational Safety and Health Administration (OSHA) originally concluded that McMurrey had died from inhaling “ground cannabis dust” but months later called it the result of a deadly asthma attack — and whether the tragedy had revealed unrecognized worker safety concerns in the cannabis industry.

Howard told WeedWeek that he didn’t know why the articles were removed:

“I worked hard on that series, as did my editor, and we felt it had the potential to help people in the industry. Anytime you have the chance to help someone avoid health problems, you take it.” — Howard, via WeedWeek

Trulieve, a Florida-based multi-state cannabis operator, paid a $14,502 settlement to OSHA in January over the incident and agreed to investigate the potential dangers of ground cannabis dust. Meanwhile, the company recently announced its departure from the Massachusetts state market.

End


New Hampshire Lawmakers Give Up on Effort to Legalize Cannabis Sales Through State-Run System

New Hampshire lawmakers on Tuesday gave up on an effort to come to a deal on allowing adult-use cannabis sales under a state-control model that was backed by Gov. Chris Sununu (R), WMUR reports. Sununu had pitched the plan after the state Senate voted 14-10 earlier this month to reject a House-approved legalization bill.

The House Commerce Committee couldn’t agree on how to proceed with a plan to implement the state-control system for cannabis, with a major issue being how the state would treat the medical cannabis operators. 

Cannabis advocates in the state and medical cannabis companies said they wanted more clarity written into the legislation rather than through a bureaucratic rulemaking process. Timothy Egan, of the New Hampshire Cannabis Association, said stakeholders “want to know the rules” before they begin investing in businesses. 

“I don’t think you can create the hopes and dreams of a businessperson on ‘Oh, we’ll get to the rules later.'” — Egan via WMUR 

Earlier this month, after years of opposition to cannabis legalization in the state, Sununu said during an interview with WMUR’s CloseUp that allowing cannabis sales through state-run shops could help “harm reduction” efforts in the state. During the interview, Sununu described cannabis legalization in the state as “probably inevitable in some way or form.” He added that the system would prevent so-called “Marijuana Miles,” which he described as the strings of “pot shop, after pot shop, after pot shop” that have popped up in Massachusetts and Maine.   

Republican House Majority Leader Jason Osborne told WMUR that “Until people are ready to get together and compromise and not demand that their preferred state of the world is the only thing they will accept, we’re not going to get anywhere.” 

End


Report: More Than 90% of California Cannabis Infected with Hop-Latent Viroid

More than 90% of cannabis in California is infected with a pathogen that effectively destroys the plant and could wreak havoc on the state’s industry, according to an SF Gate report. Hop-latent viroid (HLVd) shrivels cannabis plants, reducing how much weight they produce by as much as 30%, and cutting THC in the plant by as much as half, the report says.

The pathogen was first documented in cannabis in 2019 and it is estimated to have infected most of the state’s cannabis. In 2021, Dark Heart Nursery announced the results of a formal survey that found, after 200,000 tissue tests, 90% of California facilities included in the research had HLVd, according to a Cannabis Business Times report.

The pathogen has also been found at cannabis grows in Massachusetts, according to an NPR report from February.

Tests have been developed to determine whether a plant is infected with the pathogen — one by Oakland’s Purple City Labs can be conducted on-site and delivers results in just a few hours.

If a plant is infected by HLVd, it must be destroyed, Nick Masso of Massachusetts-based Indo Labs told NPR.

“You cannot recover from hop latent viroid,” he said.

The pathogen spreads quickly because cultivators often use cuttings from a mother plant to propagate more plants, but the new plants are already infected, and the viroid spreads exponentially.

End


New Hampshire Senate Votes to Study Legal Cannabis Sales Through State-Run Shops

The New Hampshire Senate on Thursday voted to create a commission to study cannabis legalization after Gov. Chris Sununu (R) said he would back the reforms if sales occurred in state-run dispensaries, InDepthNH reports. The amendment to create the commission was included in a bill to expand the definition of who can enroll in the state’s medical cannabis program and passed the chamber on a voice vote. 

The New Hampshire House last month passed a broad cannabis legalization bill but the Senate rejected the measure last week. The day after the Senate vote, Sununu appeared on WMUR’s CloseUp and said he would sign a cannabis legalization bill that includes a sales structure through state-run shops, similar to how the state sells liquor. In the interview, he described cannabis legalization in New Hampshire as “probably inevitable in some way or form.” 

The commission would be tasked with studying the feasibility of establishing a state-controlled system to sell cannabis. It would explore how to keep cannabis away from kids and out of schools; how to control marketing and messaging cannabis sales; how to allow local control; and how to reduce multi-drug use. 

The commission would also seek to prevent so-called “marijuana miles,” which Sununu blasted in the interview with CloseUp as “pot shop, after pot shop, after pot shop,” in Maine and Massachusetts. 

The commission would also determine how to allow adult-use sales and not impose additional taxes.    

The first meeting of the commission would be held within 45 days of the bill’s passage and a final report would be due by December 1, 2023. 

The measure still requires House approval before moving to Sununu for final approval. 

End


New Hampshire Gov. Says He Would Sign Cannabis Legalization Bill With State-Controlled Sales

During an appearance on WMUR’s CloseUp, New Hampshire Gov. Chris Sununu (R) said he would support cannabis legalization in the state under state control – similar to how the state sells liquor.  

The governor’s comments came the day after the state Senate rejected a cannabis legalization measure that had been approved by the House. 

During the interview, Sununu, who has long opposed the reforms, said he is coming around on cannabis legalization because it could help “harm reduction” and noted that other states have focused on tax revenues associated with the market.   

Sununu pointed out that polls in the state show a majority of New Hampshire residents back the reforms.  

“Whether we like it or not, this is probably inevitable in some way or form. So, let’s make sure we design a system that focuses on harm reduction as opposed to profits and when you have the system like our liquor stores – which is very unique in the country, one of the only states that has that – so, therefore, we have this amazing tool to control location, to control where it is, to control how it’s marketed, how it’s distributed, keeping it away from kids, making sure we don’t add a tax to it so we can, effectively, undercut these cartels that are bringing poly drugs in, right?” — Sununu on CloseUp     

During the interview, Sununu takes aim at so-called “Marijuana Miles” in Massachusetts and Maine, which he describes as a string of “pot shop, after pot shop, after pot shop” which he says “completely changes the fabric of the town.”  

“But with a single store in a town, or a town could say ‘We don’t want it here,’ fine, we won’t put it there. Right? Just like our liquor stores do now,” Sununu said. “Again, being able to control that aspect of it I think maintains what we are in New Hampshire, maintains a place where people want to be, and it doesn’t, kind of, overcome the town so-to-say.”  

Sununu indicated that were a bill that includes the state-control model to hit his desk, he would sign it into law.

End


Rhode Island House Approves Cannabis Advertising Bill

The Rhode Island House on Tuesday unanimously approved a bill to allow state-approved cannabis companies to advertise on billboards, the Boston Globe reports. Under the state’s cannabis legalization law, Rhode Island businesses were not allowed to advertise on billboards; however, companies in neighboring states, including Massachusetts and Connecticut, were advertising on billboards in the state.  

State Rep. Scott A. Slater (D), who introduced the cannabis legalization and advertising bills, said the state’s dispensaries were at “a serious disadvantage” because they were not allowed to advertise on billboards while out-of-state companies were already doing so. 

“Now that Rhode Island’s recreational cannabis industry is up and running, our dispensaries are facing a significant obstacle when competing with our neighbors in Massachusetts and Connecticut. … This bill will correct this inequity while also supporting these new local businesses in Rhode Island by hopefully keeping Rhode Islanders from crossing the border to shop for their cannabis in neighboring states.” — Slater to the Globe 

The bill allows the state Office of Cannabis Regulation to provide cannabis companies with forms, policies, and requirements for advertising products in the state. 

The measure still requires approval from the state Senate and by the governor.   

End


Scammers Use Boston Address for Cannabis Pickup Scheme

A Boston family’s address has been used as part of a cannabis delivery scam for which perpetrators created a fake business, known as Starlight Greens Delivery Dispensary, and collected money from would-be customers but delivered no product, WCVB reports.

Denise King, the Boston homeowner, said several people have shown up at her home seeking an order they placed through the website – but Starlight does not exist in the Massachusetts Cannabis Control Commission database. King noted that the Starlight Greens website had no telephone number, no 21-or-older site protection, and requested people pick up their order from the address listed, which runs contrary to its description as a cannabis delivery service.

King and her husband Jimmy have filed a police report with the Boston Police Department. Jimmy said he was concerned that some people can be violent.

The Massachusetts Attorney General’s Office told WCVB that it is investigating the incidents after receiving a report from the family.

The website, excellentcannabisdelivery.com, was offline as of Monday morning. A message on the site shows that the account has been suspended. A Google Maps search for “Starlight Greens Delivery Dispensary” leads to a listing in Chicago, Illinois with a website containing a misspelling – “greenleafdispentsary.com.” The link forwards users to smartcannabisdelivery.com which contains the same look as the suspended site and is also, likely, a scam.

End


SC Labs and ACT Laboratories Launch ‘Trust In Testing Certification’ to Set a Higher Standard for Cannabis Testing

The Trust in Testing Certification will help license holders and consumers identify high-quality lab testing and tested products to build more trust and transparency in the cannabis industry.

Today, ACT Laboratories and SC Labs are pleased to announce the Trust In Testing Certification, a set of enhanced national standards for cannabis testing. As the largest cannabis testing labs in the U.S., testing thousands of cannabis brands, SC Labs and ACT Laboratories are jointly taking a stand for consumer safety by outlining the most stringent lab quality requirements to ensure brands and consumers can trust their lab testing data. The initiative will help cannabis operators unify their testing protocols across their multi-state footprints, enable brands to build consumer loyalty, maintain investor and customer confidence, and, ultimately, provide safer products to the growing cannabis market.

Through over two decades of combined experience, ACT and SC have evaluated the lab regulatory standards across all states that have legalized cannabis today, and combined the most sensible and stringent quality standards to develop the Trust In Testing Certification. This includes more frequent and regular proficiency testing, the use of state-of-the-art quality management systems, and internal employee ethics and training programs, among other requirements. These standards ensure that labs are not only compliant with state regulations but are continuously raising the bar to provide partner brands and consumers with the most accurate and reliable results. This Certification is the lab’s burden to maintain for the benefit of brands, the end consumer, and ultimately the legal cannabis market at large. Brands that utilize a Trust in Testing Certified lab are allowed to put the Trust In Testing seal on their packaging, communicating to end consumers their commitment to quality.

“Today, the burden of identifying high-quality compliant labs falls on the operators and brands within each state. This leads to decentralized decision-making and considerable risk. Through the Trust In Testing Certification, brands now have a way of identifying labs that are meeting the highest threshold standards across states. It also allows brands to unify their own protocols in choosing a testing partner,” said Jeff Journey, CEO of SC Labs. “SC Labs is proud to be partnering with ACT Laboratories at the forefront of the movement to create safer cannabis through a more reliable cannabis testing landscape in the U.S. The Trust In Testing program is a transparent and collaborative process that will give consumers the confidence that they are purchasing high-quality products.”

“ACT Laboratories believes that consumers have the right to know what is in their cannabis products. This is an emerging problem: The risk of testing result inaccuracy is greater than ever for cannabis brands hoping to deliver safe and reliable products to their customers as allegations of testing fraud are rampant across the country,” said Michael Drozd, CEO of ACT Laboratories. “Poor quality testing data can adversely impact brand reputation, resulting in loss of business, hefty fines, legal action or, in some cases, licenses being revoked. And worst of all, it erodes customer confidence, has a negative financial impact, and presents a potential consumer safety risk.”

Cannabis brands are increasingly being asked by investors and other stakeholders about the controls employed by the labs testing their products. The Trust In Testing program is designed to address these concerns by enabling partners to respond to these inquiries by providing evidence of the enhanced standards used by their labs, lowering the risk of business interruption due to state regulatory action and damaging lawsuits when using a low-quality testing partner.

SC and ACT Laboratories are the founding participating labs in the Trust In Testing Certification. Cannabis brands that want to demonstrate their commitment to quality and providing accurate and reliable data may use the Trust in Testing seal on products that have been tested by a Trust in Testing Certified Lab. Similar to the “Certified Organic” seal commonly seen in the produce aisle, the Trust in Testing seal provides a simple way for cannabis consumers to feel confident that the products they are purchasing and consuming have successfully passed all potency and contaminant testing requirements.

For more detailed information on specific criteria labs that are Trust-In-Testing Certified, or to receive your Trust In Testing Certification, visit: www.trustintesting.org

###

About SC Laboratories

With more than 12 years of experience helping companies deliver safe products to the emerging marketplace, SC Labs is focused on establishing new testing standards and methodologies designed for speed, efficiency, and safety. SC Labs helps its clients navigate complex regulatory requirements while providing them unmatched scientific expertise and state-of-the-art resources. SC Labs also specializes in mitigating risk through its state-of-the-art compliance software, Chorus, to ensure cannabis businesses are up to date and compliant with the changing regulatory landscape. SC Labs is licensed and accredited in California, Oregon, Colorado, and Michigan with a growth strategy designed to serve quality cannabis and hemp brands across the nation and around the world. To learn more, visit SCLabs.com.

About ACT Laboratories

ACT Laboratories provides critical lab testing services for licensed cultivators and processors. ACT Laboratories is licensed and accredited in Illinois, Pennsylvania, Michigan, Ohio and New York with expansions into Massachusetts, New Jersey and Florida underway. ACT Laboratories is the nation’s largest testing network operating under a single private ownership structure, driving operational consistency and standardization across our footprint, and delivering a best-in-class, predictable supply chain partnership. ACT Laboratories is ISO/IEC 17025:2017 and has quality systems in place that go beyond that which is required in the Cannabis Industry, mirroring what’s seen in the pharmaceutical industry. ACT offers a suite of consultative solutions that span compliance testing, quality, formulation, and facility monitoring to optimize processes, manage risk, and drive speed to market. To learn more, visit ACTLaboratoriesinc.com

Media Contacts
Lisa Stemmer
lisa.stemmer@sclabs.com

Susan Campbell
susanc@actlaboratoriesinc.com

 

End


Blue River: A Terpene-Powered Cannabis Success Story

Blue River was founded in California as a cannabis-derived terpene company in 2015 by master extractor and inventor Tony Verzura. The company quickly took the then-nascent industry by storm and has since grown into a multi-state operation. In Spring 2023, the Blue River flagship retail store will open in Cambridge, Massachusetts. In the wake of its growth, Blue River remains family-owned and its business model centers on clean, innovative cannabis products.

Just after founding Blue River Terps, Verzura met his wife Jessica Pelletier, an entrepreneur who was working as a cannabis business consultant specializing in M&A, compliance, licensing, and general business strategy. When she met Verzura, Blue River was a Northern California brand beloved by consumers and revered by hash heads. The craft brand had a big following, and Verzura handled every detail of the business personally. When Pelletier joined the team, she saw an opportunity to pivot the business model to avoid the issues facing many family-owned Northern California cannabis companies. Knowing what she did about IP royalty leasing and brand expansion, Pelletier pitched a new direction for the operation.

Blue River shifted from a manufacturing company to a tech company in 2018. They lease their intellectual property to cannabis businesses with infrastructure proven to put products on retail shelves. “It completely changed our business model and really brought us mainstream, especially on the East Coast,” Pelletier said. “We were the first West Coast brand to launch in Florida and the East Coast in general. We partner up with MSOs that hold the same values as us, especially in the space of women-owned, women-led, commitment to diversity, and upholding the values in terms of the manufacturing side and not cutting corners in the cultivation.” The Blue River IP lease includes live rosin, vape carts, and patent-pending CBN but what is offered to consumers varies by state.

When implementing Blue River IP in new facilities, Verzura and the team are hands-on to ensure quality and brand continuity. Labs manufacturing Blue River products maintain constant communication with the cannabis inventor as he continues to R&D new products. Verzura is always testing new products like boba and astronaut ice cream. Pelletier describes eating five-star meals together and watching his mind race as it considers new flavors and methods with which to pair the cannabis terpenes. Some Verzura inventions can only be copped at pop-ups, some make it into the leasable product line, and some will only be available at Blue River farm-to-table dispensaries.

Eventually, Blue River’s founders were ready to differentiate the market and establish their own flagship retail dispensary. After five years spent pursuing a license and space in Cambridge, Massachusetts, the project is finally set to launch. Pelletier describes it as the culmination of their careers: “We are offering an entirely different dispensary experience. We’re launching ourselves as a farm-to-table destination dispensary.”

As they plan logistics, one primary concern is ensuring customers can find the same products every visit. This is an issue in many markets. In Washington state, for example, I am lucky to find the same flower product available at my neighborhood dispensary two visits in a row. Blue River plans to alleviate this common issue in Massachusetts by utilizing access to IP partner Trulieve’s supply chain. In addition, Verzura has been studying the plant for decades and has dialed in which genetics perform best in hash and which will push out quality flower to package. This knowledge is used to maximize quantity and quality while minimizing R&D time. All products available in Blue River will be completely solventless, and many will be Blue River originals. “We will be offering our signature line of products, so everything that made us famous on the West coast will only be available in our store,” Pelletier said. The store will carry other hand-selected Massachusetts brands with fifteen percent of shelf space reserved for economic empowerment and social equity companies.

The commitment to social equity carries over into staffing: Blue River hiring practices have always focused on those who have been directly harmed by the war on drugs through incarceration or familial incarceration. “It really plays into everyone’s desire to give back to the community that built us all. Anyone who is in the cannabis space, kind of like an OG, they started in that illicit market. So I think that it’s really important to not lose sight of where everybody got their roots from, to not lose sight that not everyone isn’t as lucky to make it out unscathed and have a flourishing business,” Pelletier said. “That’s why I feel that the hiring requirements and economic empowerment aspect of our business is really important. Not only do we get to make this incredible store that is very unique in concept and the first of its kind, but we also get to give back to the direct community through our hiring and incubator requirements of the state.” The company also focuses on hiring veterans, LGBTQ+, people of color, people with disabilities, and women.

Blue River is a Northern California cannabis success story that can be credited to recognizing their unique commodity and pivoting towards growth. Find Blue River products near you and check out the product line at blueriverterps.com. As for their flagship Massachusetts store, doors are expected to open sometime in March 2023 followed by a second location in Somerville.

End


Hemp Company Sues Partner Over Alleged ‘Ponzi Scheme’

A New Jersey hemp company is suing a Massachusetts biotech company claiming it operated a “Ponzi scheme” by using more than $700,000 it raised from the firm to fund its own projects, Salem News reports. In its lawsuit against the Salzman Group, Delta Technologies claims the drug development company took their money and used their machinery in other, failed, projects. 

According to the lawsuit, Salzman Group Chairman and CEO Dr. Andrew Salzman agreed to put together a “large team of scientists” to help Delta and its manager, Alexander Jacobs, obtain a patent to produce different types of hemp products. Jacobs and Delta agreed to pay the Salzman Group $20,000 per month for the project. The lawsuit alleges that, at first, Salzman told Jacobs that the team had made “dramatic” short-term progress, but the lawsuit contends that Salzman eventually stopped giving Jacobs updates or providing evidence of progress toward a commercially viable product. 

The lawsuit contends that Jacobs also agreed to provide cash to the Salzman Group to start a small laboratory in Beverly, Massachusetts to produce a “rare cannabinoid” to sell in Europe and “across the world” but Jacobs said the Salzman Group “never delivered the product on time,” and the deliveries that were made were “too small” to fulfill all of Jacob’s clients’ orders. In the lawsuit, Jacobs said he learned later that Salzman had never moved the product’s production to the Beverly laboratory. Jacobs also claims that the machinery provided to the project was never returned and that Delta has been unable to retrieve them.  

The lawsuit accuses the Salzman Group of intending to defraud, and defrauding, Delta “out of hundreds of thousands of dollars to pursue their own interests” with “no intent to ever produce the product plaintiffs needed.” The lawsuit accuses the Salzman Group of breach of contract and fraud. 

End


Vermont Cannabis Regulators Investigating Curaleaf’s Ties to Russian Oligarch

Cannabis regulators in Vermont are investigating the links between Russian oligarch Roman Abramovich and multi-state cannabis operator Curaleaf, VT Digger reports. The inquiry follows a report by Vice that found Abramovich invested $130 million and provided $194 million in loans to US cannabis firms between 2016 and 2018, with Curaleaf as the main beneficiary.  

In Vermont, Curaleaf owns Phytocare Vermont in Bennington and Vermont Patients Alliance in Montpelier. 

According to the Vice report, which come from the leak of 30,000 files from Cyprus-based accounting company Meritservus, of which Abramovich was a customer, onto the non-profit Distributed Denial of Secrets website last month, Abramovich allegedly invested $225 million into Curaleaf, then known as Palliatech, between 2015 and 2017 via a British Virgin Islands-registered company called Cetus Investments. Abramovich was allegedly referred to by Cetus staff as “Mr. Blue.” Abramovich owns Chelsea Football Club which is nicknamed the Blues. 

Vermont Cannabis Control Board chair James Pepper told VTDigger that he was unaware of the Vice report but following a VTDigger inquiry, he instructed board staff to contact Massachusetts and Connecticut to find out what they had learned. Pepper told VT Digger that Curaleaf had not mentioned Abramovich when it applied for a license to operate in Vermont’s adult-use cannabis market.  

Applicants in Vermont are required to disclose individuals with an ownership interest of 10% of more and that being dishonest could lead to a revocation of a license, Pepper told VT Digger. 

A Curaleaf spokesperson has previously told Barron’s that Abramovich “is no longer a creditor to or investor in Curaleaf.” 

Representatives for Phytocare and Vermont Patients Alliance have not commented on the allegations, while Curaleaf spokesperson Stephanie Cunha told VT Digger that the company has “fully complied with all requirements regarding disclosure of our ownership and financing in the state of Vermont.”   

According to the Curaleaf website, the company operates in Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New York, North Dakota, Ohio, Oregon, Pennsylvania, Utah, and Vermont.  

End


Ayr Wellness Hosting Expungement Clinics in Five States Next Weekend

Multistate cannabis company Ayr Wellness is holding expungement clinics in five states on February 25 and 26. The Changing Legacies series is part of the company’s Corporate Social Responsibility Program and the company is partnering with community and non-profit organizations on the endeavor.  

The event in Hartford, Connecticut on February 25, in partnership with Councilwoman Tiana Hercules, Lady Jane, UConn Law, and Rooted Community Education Group, will be held at Capitol Community College from 10:00 a.m. to 2:00 p.m. The Massachusetts event on February 25, in partnership with MassCultivatED, will be held from noon to 2:00 p.m. at the Connexion United Methodist Church in Somerville. 

In New Jersey, the event will be held in partnership with Blaze Responsibly on February 25 at 1579 Irving Street, Rahway from 10:00 a.m. to 2:00 p.m. In New York, the event is a partnership with Center for Community Alternatives which will be held at BKLYN Commons on Flatbush Avenue in Brooklyn from 1:00 p.m. to 3:00 p.m. The Pennsylvania clinic is in partnership with Cannabis Noire and will take place on February 25 at Cedar Works, located at 4919 Pentridge Street, Philadelphia.

Participants must pre-register for the Connecticut and New Jersey events, while walk-ins are permitted at the Massachusetts, New York, and Pennsylvania clinics.

In a statement, Khari Edwards, head of Corporate Social Responsibility at Ayr Wellness, said the Changing Legacies program’s goal “is to empower those most harmed by the War on Drugs with a fresh start.”

“Despite shifting public sentiment in favor of cannabis and an ever-evolving legislative and regulatory landscape, far too many individuals continue to face significant barriers to housing, employment, social services and more because of non-violent cannabis convictions.” — Edwards in a press release

Each expungement clinic will provide attendees with access to legal services, connect individuals with re-entry and wrap-around programs and, where applicable, offer financial support for obtaining critical documentation and processing fees. 

End


Jim Belushi to Give Keynote at NECANN’s 2023 New England Cannabis Convention

America’s most well-known cannabis cultivator, Jim Belushi, will join NECANN’s New England Cannabis Convention for a fireside chat on Saturday, March 11.

An accomplished actor, comedian, and musician, Jim will be sharing the lessons and skills he’s learned as a commercial grower and owner of Belushi’s Farm.

Jim joins a lineup of over 120 cannabis industry expert speakers at the convention, which features 2 sold-out exhibit halls with over 300 displays, 5 daily programming tracks, and 4 workshops over 3 days. NECANN will also present the 5th annual New England Cannabis Community Awards on Friday night, and the winners of the 2023 NECANN Cup will be announced on the exhibit floor on Saturday.

The convention will be far and away the largest B2B cannabis industry event ever presented, with over 10,000 industry professionals coming together for the 3-day event at the Hynes Convention Center in Boston.

NECANN has been developing engaging conventions for the cannabis industry since 2014, and now produces the largest convention in Massachusetts, New York, New Jersey, Illinois, Vermont, Connecticut, Maryland, Virginia, and Maine, expanding market opportunities for businesses, entrepreneurs, investors, educators, patients, advocates, and consumers. NECANN conventions hold a unique place in the event space, taking a collaborative approach with the local industries and communities, which has resulted in consistently high returns for exhibitors, sponsors, attendees, and the local cannabis market as a whole, allowing everyone to benefit and grow.

“We’re happy to say that The New England Cannabis Convention continues to defy industry norms by growing yet again in 2023,” said NECANN Founder and President, Marc Shepard. “Both exhibit halls sold out over 2 months before the show and we had the highest number of speaker applications we’ve ever seen. This event has truly become ‘The Annual Meeting of the Northeast Cannabis Industry.'”

If you’d like to see what NECANN conventions look like, click on one of the links below for a short highlight reel:

NECANN Boston
NECANN New Jersey

To learn more about joining the NECANN community as an exhibitor, sponsor, speaker, or attendee, please visit us at NECANN.com

End


First Day Cannabis Sales in Connecticut Exceed $350K

Cannabis sales in Connecticut reached $359,130 during the first day of the market’s rollout, according to Department of Consumer Protection data outlined by CT Insider. In all, there were seven dispensaries operating throughout the state on Tuesday, the first day of adult-use cannabis in the Constitution State.  

Consumers were reportedly met with prices higher than those in neighboring Massachusetts. A review of online pricing found a 100-milligram package of gummies at a Stamford dispensary cost $40 before tax, while a similar product also containing 100 milligrams of THC cost $25 at the company’s Rowley, Massachusetts dispensary. Insider also found similar products cost $25 at a New Jersey dispensary and $35 at a Rhode Island dispensary. 

New adult-use cannabis markets usually roll out with higher-than-average prices but prices often come down and stabilize as the market matures. 

Most Connecticut dispensaries were selling 3.5-gram containers of flower for $50, which usually cost about $5 less at Massachusetts retail shops.   

Adam Wood, president of the Connecticut Cannabis Chamber of Commerce, told Insider he expects that “prices will fluctuate” as supply and demand change. Currently, there are just four licensed cultivators in the state. Wood estimates as many as 30 to more than 40 cultivators could receive state licenses. 

End


Coda Signature: Delivering Chef-Crafted Cannabis Confections

There is an incredible synergy between chocolate and cannabis. Both contain the “bliss molecule” anandamide that signals the brain to feel joy. Coda Signature, founded in Colorado in 2015, is a brand of chef-crafted cannabis confections capturing this synergy. Coda’s flagship line of chocolate bars is joined by pates de fruit made with all-natural ingredients and dusted in aromatic sugars and spices. Each product is crafted with intention, using quality ingredients to build a flavor profile that goes deeper than simply tasting good. But they do, in fact, taste good.

Co-founder and Chief Innovation Officer Chef Lauren Gockley, the mind behind Coda Signature, sat down to speak with Ganjapreneur about the brand, developing new flavors, and her plans for the future. “Chocolate not only spoke to the science side of my brain but also the creativity side of my brain, it kind of struck this really beautiful balance where chocolate has very clear guidelines but it’s an incredible medium to work with as a craftsman,” Gockley said. “Chocolate not only is a phenomenal ingredient, it has a very rich history from the Mayans and the Aztecs, it can be molded in so many form factors, and kind of at its core, it’s something that brings joy to almost everyone. Chocolate became my love language.”

The chef’s interest in food developed early alongside her grandmother in the kitchen but before pursuing a career as a chef, she explored a profession in music. Music wasn’t the right fit, and Gockley transitioned into pastry where she appreciated the defined rules of baking science. She began working as a raw Vegan chocolatier, using medicinal herbs and ingredients that weren’t traditionally accepted as tasting “good”— chocolate was her preferred medium for self-expression. The experience of crafting tasty confections with medicinal herbs gave her confidence with cannabis as an ingredient that she could embrace rather than try to hide its natural flavor. Strong, engaging flavors became a mission for Coda, and the team began to develop the brand.

Music has always been a presence in Gockley’s life, and it became the language of the brand. If you look closely you’ll find small nods to music theory in the branding. “It’s an intimate connector the same way the culture of cannabis is — we’re sharing a joint and experiencing a high together. The music helps me and the team to communicate,” Gockley said.

Each edible flavor is built to communicate an experience to the consumer, like Coffee + Donuts which Gockley formulated to bring you right back to your neighborhood donut shop’s hard-backed booth with a squeaky vinyl cushion, where you’d enjoy a pink sprinkle and a cup of hot black coffee. The chocolate bar doesn’t contain donuts; instead, she takes a concept (like coffee and donuts), breaks it apart, and puts it back together using layered flavors to bring the consumer into a moment. Rather than just adding nuts to milk chocolate, she ventures to add an element of surprise, something that has deepened the consumer relationship with the product.

It takes a village to taste test and build new innovative flavors, starting with non-medicated taste testing for a wide swath of their team, friends, and trusted advisors. Once they tweak that recipe, they introduce cannabis sourced from trusted extractors. Originally, Coda set out to do all extraction in-house but as the industry developed and the brand grew into new markets, it was necessary to find an extraction artist to take the reins of that portion of the work. “We are great at making confection so let’s let the brilliant craftsmen and the extractors shine in what they do,” Gockley said. From cannabis to chocolate, every ingredient in Coda edibles is intentional and finely sourced, and Gockley’s culinary network came in handy as they sought out a chocolate partner.

During her culinary career, Gockley worked with French chocolate brand Valhrona who recommended Coda work with Ecuadorian chocolate company Republica de Cacao. Both Coda and Republica de Cacao were in their infancy. Before settling on their chocolate partner, Gockley visited the factory, their cacao fields, and the farm in the Andes mountains where cows are milked by hand. Now, six years later, the company has built a chocolate specifically for the cannabis brand that matches their preferred flavor profiles- highlighting the cinnamon, hazelnut, and butterscotch in the milk chocolate and earthy dark chocolate that compliments the flavor of cannabis.

The Colorado-born brand learned as it expanded that each market has a particular palate. In Colorado, Coda sunsetted products that played with sweetness and spice like Pineapple Jalapeño and Fire and Orange, but consumers elsewhere loved the spicy chocolates. Cream and Crumble, a new white chocolate bar that plays on flavors of a lemon cheesecake, caters to Coloradans’ sweet tooth. The bar features a tang of sour cream with the crunch of a cinnamon streusel, layering a flavor experience that always evokes noticeably joyous surprise, and watching people enjoy that crescendo simply tickles Gockley: “That’s worth a million bucks.”

As Coda enters new markets — as it did most recently in Massachusetts, and as it plans to do in Illinois later in 2023 — Gockley is proud that the brand has maintained its mission of crafting fine confections, “That was a priority when we were starting the company, this was going to be a flavor-driven brand with quality ingredients with chocolate at the forefront.” And they’ve done exactly that.

End


Sean ‘Diddy’ Combs Agrees to Purchase Cresco Labs and Columbia Care

Sean “Diddy” Combs has agreed to purchase the cannabis operations of Cresco Labs Inc. and Columbia Care Inc. in three states for up to $185 million, The Wall Street Journal reports. The deal still requires regulatory approval and the company would need to divest assets in several states before it is finalized.

Under the proposal, the new company controlled by Combs would acquire nine retail stores and three production facilities in New York, Massachusetts, and Illinois. Combs’ company would pay $110 million in cash and $45 million in debt financing, plus additional money based on certain market-growth milestones. Cresco and Columbia agreed to merge in March in a $2 billion deal.

In an interview with the Journal, Combs seemed to describe legalization as “diabolical.”

“How do you lock up communities of people, break down their family structure, their futures, and then legalize it and make sure that those same people don’t get a chance to benefit or resurrect their lives from it?” — Combs to WSJ

Between 2010 and 2018, Black people were 3.6 times as likely as white people to be arrested for cannabis possession in the U.S., despite similar rates of cannabis use, according to data from the American Civil Liberties Union.

A June 2021 Leafly report utilizing data from Whitney Economics found that Black-owned businesses comprise just 2% of the roughly 40,000 cannabis companies in the U.S.

“Two percent? All the years, all the pain, all the incarceration,” Combs said. “To me, it was important to do a big deal like this.”

Combs’ other consumer brands include Sean John, a partnership with Diageo PLC on Cîroc vodka and DeLeón tequila.

Editor’s note: A previous version of this article stated incorrectly that Whitney Economics had published the 2021 report investigating Black-owned businesses in the cannabis industry. The ‘Seeds of Change’ article, authored by Janessa Bailey, was actually published by Leafly.

End


Jim Belushi Opens Retail Cannabis Dispensary on Tribal Land in Upstate New York

A business in partnership with actor Jim Belushi’s cannabis company was awarded a license to sell cannabis on Saint Regis (Akwesasne) Mohawk Tribe territory in upstate New York. Belushi’s Farm Akwesasne, majority owned by Zachary Oakes, will operate as a license partner of the Oregon-based Belushi’s Farm, which has additional license partners in California, Colorado, Oklahoma, Illinois, Massachusetts, and other states.

The fees collected from the retail sale of cannabis products help support community programs and services for the Tribe and its members, the Saint Regis Mohawk Tribal Council said in a press release. 

A tribal spokesperson told Syracuse.com that there are now at least a dozen licensed adult-use dispensaries on Akwesasne territory. The Tribe began issuing licenses last year after several unauthorized shops opened following the legalization of cannabis in New York. The state has not yet issued licenses for businesses under the purview of the state but last week released regulations for Conditional Adult-Use Retail Dispensary licenses, including guidance for in-house, drive-thru, and delivery options.   

Belushi was previously a cast member of “Saturday Night Live,” appeared on “Twin Peaks,” and was the star of the television series “According to Jim.” He’s also appeared in the films “Trading Places” and “Only the Lonely.” His Oregon cannabis farm was featured in a Discovery Channel series called “Growing Belushi.” 

Belushi was present at the October 27 ribbon-cutting and grand opening of the location along with members of the tribal community and government. 

Editor’s note: A previous version of this article incorrectly said Belushi’s Farm was awarded the cannabis retail license by Saint Regis (Akwesasne) Mohawk tribal authorities but the license is actually held by Belushi’s Farm Akwesasne, owned by Zachary Oakes.

End


Canopy Growth Announces ‘Fast Track’ Plan Into U.S. Market

Canadian cannabis company Canopy Growth Corporation last week announced it plans to “fast track” its entry into the U.S. market. The company said it is consolidating its U.S. assets into a new holding company, Canopy USA LLC.  

David Klein, Canopy CEO, said the strategy enables the firm to “take control” of its own destiny “and capitalize on the once-in-a-generation opportunity in the largest cannabis market in the world.” 

“We expect to unleash the full power of Canopy’s scalable and ideally-positioned U.S. cannabis ecosystem to unlock potential expansion opportunities. This strategy and positioning are true differentiators, which we expect to enable our investors and brands to realize value in the near term while positioning Canopy for profitable growth and a fast start upon U.S. federal permissibility.” — Klein in a press release 

The U.S. cannabis market is expected to reach $50 billion by 2026, according to MJBiz data outlined by Canopy. 

Canopy’s U.S. portfolio includes Acreage Holdings Inc.; the option to acquire Moutain High Products LLC and its Wana brand; and the option to acquire Jetty, a top 10 California brand. 

The firm also has the option to exercise warrants on approximately 13.7% of TerrAscend Corp.  

Constellation Brands, the spirits giant that acquired a stake in Canopy in 2017 for $190 million, said it planned to transition existing common shares ownership interest in Canopy into new exchangeable shares, which would protect “Constellation shareholder value while retaining an interest in Canopy Growth through non-voting and non-participating shares.”     

Bill Newlands, Constellation’s president and CEO, said the company believes the conversion “will maintain Constellation’s ability to realize the potential upside” of its investment in the cannabis firm. 

“At the same time, this transaction and the surrender of our warrants are expected to eliminate the impact to our equity in earnings, mitigate risk to our organization, and further reinforce our intent to not deploy additional investment in Canopy aligned with Constellation’s previously stated capital allocation priorities,” he said in a statement. 

Collectively, Canopy’s footprint currently spans 21 states, including Arizona, Arkansas, California, Colorado, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, Pennsylvania, Ohio, Oklahoma, and Oregon. 

End


Mother Facing Felony Charges After Son Allegedly Dies by Delta-8 Toxicity

Virginia mother Dorothy Annette Clements is facing felony murder and child neglect charges after her four-year-old died after ingesting “a large amount” of delta-8 THC gummies, CNN reports. Although it is less potent, delta-8 THC carries similar effects as delta-9 THC, the most common cannabinoid found in cannabis. Delta-8 has also been ruled to be federally legal as a hemp-derived substance under the 2018 Farm Bill.

The death, which occurred on May 8 after the four-year-old was put on life support on May 6 due to a “medical emergency,” is considered by Virginia’s Department of Health to be accidental, and “the cause of death is delta-8 toxicity,” according to the CNN report.

“Detectives believe the child ingested a large amount of THC gummies,” Major Troy Skebo of the Spotsylvania Sheriff’s Office told CNN. “The attending doctor told detectives that if medical intervention occurred shortly after ingestion, it could have prevented death. Statements made to detectives by the mother did not match evidence seized at the home.”

Clements was indicted by a grand jury last week and taken into custody on Thursday. She told WUSA9 before she was charged that the toddler was sitting beside her when she noticed he was having trouble breathing.   

WUSA9 reported that Clements had realized the child had eaten a gummy and called poison control.

In September 2021, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) issued warnings concerning the use of and experimentation with delta-8 THC products. 

“The health effects of delta-8 THC have not yet been researched extensively and are not well-understood,” the CDC wrote in a Health Advisory report. “However, delta-8 THC is psychoactive and may have similar risks of impairment as delta-9 THC. As such, products that contain delta-8 THC but are labeled with only delta-9 THC content rather than with total THC content likely underestimate the psychoactive potential of these products for consumers.”

There are currently zero recorded deaths attributed to a cannabis or THC overdose.

End


Trulieve Pushes Back Against Media Coverage of Employee’s Death at Holyoke Facility

Trulieve is pushing back against what it describes as “false reporting” surrounding the death of Lorna McMurrey, the 27-year-old who died at the company’s Holyoke, Massachusetts facility caused by what the Occupational Safety and Health Administration (OSHA) initially described as inhaling “ground cannabis dust.” 

In a press release, Trulieve outlined the air quality systems in place at the Holyoke facility, saying that “appropriate industrial air systems” were “installed and at all times operated” within the processing areas of the facility and that the Holyoke facility in particular “has a special industrial air filtration system that exchanges the air in the grinding room” which had been certified by an independent engineer. The company said it also uses Abatement Technology Air Scrubbers, described as “two stage air carbon filtrations for odor control” that exchange and clean the air at regular intervals.  

Trulieve said that its employees are provided N95 masks “contrary to reports” that claimed the company “only offered paper masks” and that McMurrey wore an N95 mask “for at least a portion of the day, contrary to reports” that allege she was wearing a paper mask. 

In the press release, Trulieve laid out what it describes as the events that led up to McMurrey’s death:   

“On January 4, 2022, Ms. McMurrey arrived at the Holyoke facility for her regular shift. She spent the day working in the pre-roll area, contrary to reports stating she was in the flower grinding room. 

When Ms. McMurrey indicated to her supervisor that she was not feeling well, she was told that she could take the day off with pay, contrary to reports stating we insisted she continue working. However, she opted to return to work in the pre-roll area. 

When Ms. McMurrey began to appear to be in distress, Trulieve followed appropriate protocols. A manager promptly called 911. A trained member of the Trulieve security team began to provide CPR, contrary to reports stating that no CPR assistance was provided. EMS arrived quickly and took over management of the response. 

Upon arrival at the facility, it took EMS personnel less than one minute to begin medical attention to Ms. McMurrey, contrary to reports stating that it took medics a long time to reach the patient once they arrived at the facility. 

Ms. McMurrey was taken to Baystate Hospital where, unfortunately, she passed away on Friday, January 7.” — Truvlieve in a press release, Oct. 20, 2022 

The company said its managers, security, and supervisors are “regularly” trained in the use of Automated External Defibrillators (AEDs) and that all three employees who administered CPR to McMurrey had participated in “full certification CPR training” less than a month before the incident. 

Trulive said that “contrary to initial reports” the company reported that McMurrey had collapsed to both the Massachusetts Cannabis Control Commission and OSHA within 24 hours of the incident and reported her passing to both organizations the following day. 

Regarding the OSHA investigation, Trulieve said OSHA took “multiple air samples” which “complied with relevant standards” and the agency only issued citations “under the hazard communication standard.” According to OSHA’s website, the Hazard Communication Standard requires that “all employers with hazardous chemicals in their workplaces must have labels and safety data sheets for their exposed workers, and train them to handle the chemicals appropriately.”

Trulieve is contesting those citations, which totaled $35,219. 

“Our thoughts are with the McMurrey family for their loss. Trulieve will continue to operate its facilities in a manner that fully protects the health and safety of all employees,” the company said in its press release. “We are confident we did so in January and will continue to do so going forward.” 

End


Authorities Investigating Details Surrounding the Death of Lorna McMurrey

Massachusetts authorities are investigating the death of Lorna McMurrey, the employee who died in January at a Trulieve Holdings LLC facility in Holyoke, Western Mass News reports. The investigation is not criminal in nature but Holyoke Fire Department Capt. David Rex told Western Mass News that the medical examiner and police are focused on the call made to the fire department on January 7 around 11 p.m.    

The federal Occupational Safety and Health Administration (OSHA) concluded in its report that McMurrey, 27, died from inhaling “ground cannabis dust.” 

“Filling pre-rolls She (sic) said she couldn’t breathe. Not being able to breathe Marijuana kief (dust) At 11:00 p.m. on January 7, 2022, an employee was grinding cannabis flowers, and packaging ground cannabis in pre-rolls. The employee could not breathe and was killed, due to the hazards of ground cannabis dust.” — OSHA in the January 7 report   

OSHA filed three citations, including more than $35,000 in fines, against Trulieve related to a lack of appropriate training and available safety information for hazardous chemicals. Trulieve is contesting the fines. 

There is no exposure limit in place per OSHA for exposure to “ground cannabis dust.”

In a statement to Western Mass News, Trulieve said, “Our hearts go out to Ms. McMurrey’s family, friends, and colleagues as the circumstances around her passing have recently resurfaced, resulting in their having to re-experience their loss.” 

McMurrey’s death was first reported by The Young Jurks podcast.   

“Out of respect for the family’s privacy, we are not going to provide any details as to the specifics of that day. However, OSHA conducted a thorough investigation of the Holyoke facility. [Personal Protective Equipment] was available onsite,” the spokesperson told Western Mass News. “They tested the air quality throughout the facility and the samples were all well below acceptable ranges. OSHA did issue citations related to communication standards and Trulieve has contested those findings. We cherish and value all of the 9,000 employees who make Trulieve a family and the safety of our team members is paramount to our core values.” 

End


Nidhi Lucky Handa: Consumer-Friendly Cannabis Products Under a Multistate Lifestyle Brand

LEUNE is a California-based cannabis company that has expanded into Arizona and Maine since its launch. The lifestyle company was founded by Nidhi Lucky Handa, a former celebrity talent manager, and a luxury brand communications expert. LEUNE brands and sells packaged cannabis flower, one-time-use vape pens, and rosin gummies.

In this written interview, Nidhi breaks down the reasoning behind LEUNE’s branding and market expansion, how they source their products, the quality control that goes into sourcing and branding the company’s consumer packaged goods across multiple states, and more.

Scroll on to read the full interview!


Ganjapreneur: What have you enjoyed about starting a business? Alternatively, what are the hard parts of entrepreneurship that can be glossed over?

Nidhi Lucky Handa: Great question – much of the time founder life creates tunnel vision and laser focus on moving forward, so it’s nice to pause and reflect on the highs as well as the…challenges!

The parts I love are so easy to see in the rear view – building a team, a culture, getting the big ideas from paper to production, celebrating the smallest of victories – but the reality is, I’m learning now that the best parts are actually in the process, in the now. I feel so immensely grateful to have a business in this dynamic industry and to have the opportunity to tell the stories that are important to me with a team I adore and learn from everyday.

The harder parts are the ones you’d expect – making choices that are in the best interest of the company even when they’re at the expense of a part of the vision. It’s a constant pivoting exercise running a business in an emerging industry and that means (sometimes) letting go of the passion projects or putting them on ice for a later time.

When you couldn’t find adult-use products catered to women on dispensary shelves, you identified a gap in the market and decided to create LEUNE. How do you believe LEUNE has filled this gap, and how does its branding and marketing advance this concept?

I was (and still am) less interested in gender and more interested in building something for a consumer (like me and my peer group) who is excited about legal weed, but isn’t/wasn’t being spoken to. I wanted to build something that was aesthetic and stylish, well-priced and high on quality – that’s where LEUNE was born.

We’ve been thoughtful about everything from consumer arc to buying habits. We’ve paid close attention to the consumers who want to initially just dip their toe in the pond but quickly convert to regular customers – we’ve listened closely to what makes folks stick around and what makes them leave.

I’ve put a strong emphasis on the creative spirit at LEUNE because that’s what resonates with me as a consumer. Our campaigns are ethereal, beautiful and relatable all at the same time.

What branding components signal to the ideal cannabis consumer that LEUNE products are for them? How else does the brand engage the consumer in the retail store?

That’s a good question- I believe that consumers who are drawn to LEUNE branding are attracted to the clean, modern, color-blocked aesthetic and simple overall architecture of the brand.

What attracted LEUNE to Maine as you expanded into new markets?

Maine is close to my heart as a Massachusetts native. I spent many a summer holiday in Portland growing up. The food and craft culture are all in such perfect alignment with who we are as a brand – small, unique, happily in our own skin. We were thrilled when the stars aligned and the opportunity presented itself. I love shopping the dispensaries in Maine and soaking in the passion for the plant that the local market clearly hones in on.

Did LEUNE complete any market research before releasing products in Maine? What research tools or resources were helpful during the expansion?

Yes, of course! We do so for every market. We look carefully at existing brand presence, product assortment, price points and quality. In order to build out a plan and product assortment that fits well for the market in question we do extensive research. In terms of tools, we talk to experts in the market, visit stores and go through retail menus – it’s the most accurate and up to date way to get this kind of data – albeit very time consuming.

What is Honestly Grown, and what moved the team to create the publication?

Honestly Grown is LEUNE’s quarterly lifestyle magazine. It focuses on raising the bar surrounding the conversation on cannabis. With activism and social justice at its forefront, Honestly Grown aims to bring awareness to the reader through interviews, anecdotal submissions, art and education.

We were inspired to create a magazine because we wanted to use our creative resources to highlight the importance of social justice in cannabis, such a s restorative justice for those still currently incarcerated for nonviolent cannabis crimes. We are also aiming to destigmatize conversations around cannabis and promote conversations that normalize the plant in every way.

Why did the brand choose to expand its product offerings, and what dictated that the new product would be a gummy candy?

From inception it was always clear to me that LEUNE would be vertical agnostic – even at launch with four SKUs, it was two all-in-one vapes and two pre-rolls.

We are proudly a consumer-first brand – and in an industry that is so young and constantly evolving, we want to listen to the consumer and understand what, why, where and how often they want to consume. In order to do that, we have to give them choice and pay attention to the evolving use-case of different form factors.

As for the gummies – those took the most R+D, time and iteration to get right, and I couldn’t be prouder. Rosin, gluten free, vegan, taste GREAT…they check all the boxes of a discerning consumer.

Who is your manufacturing partner in California? How do you oversee quality control using an offsite manufacturing facility?

We’ve worked with over a dozen facilities across the state to ensure LEUNE products stay on the shelf! We’ve learned so much about the importance of super buttoned up, specific SOPs and rigorous QA/QC check-ins over the years. It’s essential that brands stay vigilant and particular about the consistency of the products to ensure that customers have a great experience again and again.

How do you manage quality control as you’ve expanded into new markets? Can a consumer expect the same quality pre-roll from a California and Arizona dispensary?

As a brand this is of utmost concern and care. We vet our partners through-and-through.

Does LEUNE use sales teams, software, or a combination of the two to reach its retail partners?

It looks a little different in every market. Here in CA, LEUNE products are distributed and sold by a full service distributor. With that relationship we have access to a robust team of professionals throughout the state who can reach all corners of California.

When a new store puts in an order, does the brand educate retail staff before the products hit shelves?
ABSOLUTELY! Education (at every level) is the most important part of sales in my opinion! Ensuring that the budtenders are able to speak to the UVP of the brand is essential to strong sell through and retention.

What types of cannabis products do you think will gain popularity among California consumers in the coming year, and why?

​ROSIN GUMMIES! Consumers are starting to learn the benefits of rosin in edibles – no more distillate hangover for starters. It’s a game changer and once you try a better quality product (like LEUNE Gem Drops) it’s impossible to go back.

Do you have advice for entrepreneurs interested in building a consumer-focused brand?

The cliche is true – be authentic, find a problem and fix it, know what your UVP is!


Thanks again, Nidhi, for answering our questions! Our readers can visit LEUNE.co to learn more.

End